The results will lead on to the start of TOPARP - B, a second part of the trial in which only men with detectable DNA repair mutations will
receive olaparib.
27 patients underwent surgery and 35
received olaparib / TMZ.
Not exact matches
A Randomized Phase 2 Trial of Cediranib and
Olaparib Compared to Bevacizumab in Patients with Recurrent Glioblastoma who have not
received Prior VEGF Therapy
Tumours shrank in about 60 % of women who
received the targeted drug, called
olaparib (Lynparza), compared with 29 % of those who
received chemotherapy.